Martha A Belury1, Rachel M Cole1,2, Rebecca Andridge3, Ashleigh Keiter3, Subha V Raman4, Maryam B Lustberg5, Janice K Kiecolt-Glaser6. 1. Program of Human Nutrition, Department of Human Sciences, The Ohio State University, Columbus, OH, USA. 2. The Ohio State University Nutrition Doctoral Program, The Ohio State University, Columbus, OH, USA. 3. Division of Biostatistics, College of Public Health, The Ohio State University, Columbus, OH, USA. 4. Krannert Institute of Cardiology, Indiana University College of Medicine, Indianapolis, IN, USA. 5. Division of Oncology, College of Medicine, The Ohio State University, Columbus, OH, USA. 6. Department of Psychiatry, Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA.
Abstract
BACKGROUND: Sarcopenia may hasten the risk of mortality in women with breast cancer. Long-chain omega-3 (n-3) polyunsaturated fatty acids (LCn-3PUFAs) may favor muscle mass which, in turn, could enhance resilience of cancer patients toward cancer treatment. OBJECTIVES: The objective of this study was to measure the relation of erythrocyte LCn-3PUFA concentrations with lean mass, grip strength, and postprandial energy metabolism in women with newly diagnosed breast cancer. METHODS: This cross-sectional analysis evaluated women (n = 150) ages 65 y and younger who were recently diagnosed with breast cancer (stages I-III). Erythrocyte LCn-3PUFA composition was measured using GC. Body composition was measured by DXA. Grip strength was assessed at the same visit. Postprandial energy metabolism was measured for 7.5 h after the consumption of a high-calorie, high-saturated-fat test meal using indirect calorimetry. Associations of fatty acids with outcomes were analyzed using multiple linear regression models and linear mixed-effects models. RESULTS: The ω-3 index, a measurement of LCn-3PUFA status, was positively associated with appendicular lean mass (ALM)/BMI (β = 0.015, P = 0.01) and grip strength (β = 0.757, P = 0.04) after adjusting data for age and cancer stage. However, when cardiorespiratory fitness was also included in the analyses, these relations were no longer significant (P > 0.08). After a test meal, a higher ω-3 index was associated with a less steep rise in fat oxidation (P = 0.02) and a steeper decline in glucose (P = 0.01) when adjusting for age, BMI, cancer stage, and cardiorespiratory fitness. CONCLUSIONS: The ω-3 index was positively associated with ALM/BMI and grip strength in women newly diagnosed with breast cancer and was associated with altered postprandial substrate metabolism. These findings warrant further studies to determine whether enriching the diet with LCn-3PUFAs during and after cancer treatments is causally linked with better muscle health and metabolic outcomes in breast cancer survivors.
BACKGROUND: Sarcopenia may hasten the risk of mortality in women with breast cancer. Long-chain omega-3 (n-3) polyunsaturated fatty acids (LCn-3PUFAs) may favor muscle mass which, in turn, could enhance resilience of cancer patients toward cancer treatment. OBJECTIVES: The objective of this study was to measure the relation of erythrocyte LCn-3PUFA concentrations with lean mass, grip strength, and postprandial energy metabolism in women with newly diagnosed breast cancer. METHODS: This cross-sectional analysis evaluated women (n = 150) ages 65 y and younger who were recently diagnosed with breast cancer (stages I-III). Erythrocyte LCn-3PUFA composition was measured using GC. Body composition was measured by DXA. Grip strength was assessed at the same visit. Postprandial energy metabolism was measured for 7.5 h after the consumption of a high-calorie, high-saturated-fat test meal using indirect calorimetry. Associations of fatty acids with outcomes were analyzed using multiple linear regression models and linear mixed-effects models. RESULTS: The ω-3 index, a measurement of LCn-3PUFA status, was positively associated with appendicular lean mass (ALM)/BMI (β = 0.015, P = 0.01) and grip strength (β = 0.757, P = 0.04) after adjusting data for age and cancer stage. However, when cardiorespiratory fitness was also included in the analyses, these relations were no longer significant (P > 0.08). After a test meal, a higher ω-3 index was associated with a less steep rise in fat oxidation (P = 0.02) and a steeper decline in glucose (P = 0.01) when adjusting for age, BMI, cancer stage, and cardiorespiratory fitness. CONCLUSIONS: The ω-3 index was positively associated with ALM/BMI and grip strength in women newly diagnosed with breast cancer and was associated with altered postprandial substrate metabolism. These findings warrant further studies to determine whether enriching the diet with LCn-3PUFAs during and after cancer treatments is causally linked with better muscle health and metabolic outcomes in breast cancer survivors.
Authors: Louiza S Velentzis; Mohammed R Keshtgar; Jayne V Woodside; Anthony J Leathem; Ann Titcomb; Katherine Anne Perkins; Monika Mazurowska; Victoria Anderson; Kayleigh Wardell; Marie M Cantwell Journal: Breast Cancer Res Treat Date: 2011-01-11 Impact factor: 4.872
Authors: Gordon I Smith; Philip Atherton; Dominic N Reeds; B Selma Mohammed; Debbie Rankin; Michael J Rennie; Bettina Mittendorfer Journal: Am J Clin Nutr Date: 2010-12-15 Impact factor: 7.045
Authors: Heather Greenlee; Marilyn L Kwan; Isaac Joshua Ergas; Karen J Sherman; Sarah E Krathwohl; Christine Bonnell; Marion M Lee; Lawrence H Kushi Journal: Breast Cancer Res Treat Date: 2009-01-31 Impact factor: 4.872
Authors: Anne Dee; Roberta McKean-Cowdin; Marian L Neuhouser; Cornelia Ulrich; Richard N Baumgartner; Anne McTiernan; Kathy Baumgartner; Catherine M Alfano; Rachel Ballard-Barbash; Leslie Bernstein Journal: BMC Cancer Date: 2012-08-08 Impact factor: 4.430
Authors: Mostefa Fodil; Vincent Blanckaert; Lionel Ulmann; Virginie Mimouni; Benoît Chénais Journal: Int J Environ Res Public Health Date: 2022-06-28 Impact factor: 4.614